Get the Stockscreener App
2.9543
6.62%
-0.2096
Arcadia Biosciences Inc stock is traded at $2.9543, with a volume of 2,624.
It is down -6.62% in the last 24 hours and down -8.54% over the past month.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
See More
Previous Close:
$3.1639
Open:
$3.04
24h Volume:
2,624
Relative Volume:
0.39
Market Cap:
$4.30M
Revenue:
$5.67M
Net Income/Loss:
$-13.98M
P/E Ratio:
-0.2091
EPS:
-14.13
Net Cash Flow:
$-15.30M
1W Performance:
-1.19%
1M Performance:
-8.54%
6M Performance:
-7.10%
1Y Performance:
+45.54%
1-Day Range:
$2.74
$3.05
1-Week Range:
$2.74
$3.40
52-Week Range:
$1.9001
$10.31
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Name
Arcadia Biosciences Inc
Sector
Industry
Phone
530-756-7077
Address
202 COUSTEAU PLACE, DAVIS, CA
Compare RKDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
2.9543 | 4.30M | 5.67M | -13.98M | -15.30M | -14.13 |
|
KHC
Kraft Heinz Co
|
29.46 | 35.56B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
57.51 | 32.31B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.37 | 28.46B | 12.75B | 1.34B | 1.13B | 3.87 |
|
MKC
Mccormick Co Inc
|
75.32 | 20.81B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
30.58 | 16.80B | 11.92B | 805.04M | 1.01B | 1.46 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-20 | Reiterated | H.C. Wainwright | Buy |
| May-12-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-09-15 | Initiated | Credit Suisse | Outperform |
| Jun-09-15 | Initiated | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Stock (RKDA) Latest News
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Arcadia Biosciences regains IP rights, amends agreement - Investing.com
Arcadia Biosciences IncEnters Agreement To Transfer Patents And Rights With A Third Party- SEC Filing - MarketScreener
Arcadia Biosciences regains IP rights, amends agreement By Investing.com - Investing.com UK
Head-To-Head Contrast: Lendway (NASDAQ:LDWY) versus Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (NASDAQ:RKDA) vs. Lendway (NASDAQ:LDWY) Critical Analysis - Defense World
Arcadia Biosciences Inc. (RKDA) reports earnings - qz.com
Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 - MSN
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock - MSN
Arcadia Biosciences Earnings Call Highlights Zola Growth - TipRanks
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Call Highlights: Strong Zola Sales Propel ... - Yahoo Finance
Arcadia Biosciences Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call transcript: Arcadia Biosciences Q4 2024 sees revenue growth By Investing.com - Investing.com Canada
Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
Arcadia Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights - Quantisnow
Arcadia Biosciences (RKDA) Expected to Announce Earnings on Thursday - Defense World
Arcadia Biosciences Inc expected to post a loss of 89 cents a shareEarnings Preview - TradingView
Arcadia Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call - Business Wire
Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com - Defense World
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders - Business Wire
Arcadia Biosciences CFO Kawakami buys $1,743 in stock - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerEVGR, QTRX, RKDA, EBTC - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTC - GlobeNewswire Inc.
Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock By Investing.com - Investing.com South Africa
Arcadia Biosciences CFO Kawakami buys $1,743 in stock By Investing.com - Investing.com Canada
Chief Financial Officer Kawakami Mark bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 35% to 2,681 units (SEC Form 4) - Quantisnow
Chief Executive Officer Schaefer Thomas J. bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 33% to 2,819 units (SEC Form 4) - Quantisnow
StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA) - Armenian Reporter
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com - Defense World
Arcadia Biosciences Inc Stock (RKDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):